Vortioxetine and the California Workers' Compensation Pharmacopoeia

Is Vortioxetine on the California Workers' Compensation Pharmacopoeia?

Vortioxetine is not listed as a default preferred medication in the California Workers' Compensation Medical Treatment Utilization Schedule (MTUS). That means it is not automatically on the pharmacopoeia that guides first-line prescribing for most psychiatric conditions covered by workers' comp in California. Coverage is still possible, but it typically requires a justification that preferred options have failed or are not appropriate for the worker.

How the California Pharmacopoeia Shapes Formulary Decisions

The MTUS serves as the state's de facto pharmacopoeia for workers' compensation. It ranks medications by preference tiers and specifies when a drug can be prescribed without prior authorization. For antidepressants, the schedule favors older classes and certain newer agents that have broad evidence for occupational injury-related depression or anxiety. Vortioxetine, while approved by the FDA for major depressive disorder, sits outside these preferred tiers because the MTUS relies on a specific evidence base tied to occupational injury, not general psychiatric practice.

When Vortioxetine May Be Approved

A treating physician can request a formulary exception for vortioxetine if the patient has documented intolerance, lack of efficacy, or contraindications to preferred antidepressants. In California, this usually means submitting a Utilization Review (UR) request with clinical notes showing that at least one MTUS-preferred agent was tried and failed. The physician must link the medication to the accepted injury and explain why the preferred alternatives are unsuitable for that specific worker.

Common Preferred Antidepressants in the MTUS

• Amitriptyline
• Nortriptyline
• Duloxetine
• Fluoxetine
• Sertraline
• Citalopram

What This Means for Patients and Prescribers

Because vortioxetine is not on the default pharmacopoeia, patients may face delays or denials if the prescribing doctor does not follow the UR process. The burden of proof rests on the treating team to demonstrate medical necessity. In practice, this means collecting detailed records of prior treatment attempts, side-effect profiles, and how the worker's job demands interact with the medication's tolerability. Workers who experience cognitive side effects from preferred antidepressants may find vortioxetine's distinct mechanism helpful, but they must still navigate the state's step-therapy expectations.

Alternatives and Adjuncts Within the California Formulary

If vortioxetine is not approved, the MTUS offers several alternatives for depression or anxiety related to a work injury. Bupropion is sometimes considered when fatigue or concentration is prominent, though it also falls outside the core preferred list and may require UR. Combination therapy with a preferred SSRI and a targeted adjunct, such as low-dose buspirone for anxiety, remains a common pathway. The formulary also supports non-pharmacologic treatments like cognitive behavioral therapy, which can reduce or replace the need for a non-preferred antidepressant.

Steps to Pursue Coverage

Bottom Line

Vortioxetine is not on the default California workers' compensation pharmacopoeia, but it is not categorically excluded. Coverage depends on a well-documented UR process that shows failure or intolerance of preferred options and ties the prescription to the accepted injury. Patients and prescribers who prepare the clinical evidence carefully have the best chance of obtaining approval, even when the medication sits outside the state's preferred formulary.